Page last updated: 2024-10-24

camostat and Cell Transformation, Neoplastic

camostat has been researched along with Cell Transformation, Neoplastic in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daniluk, J1
Liu, Y1
Deng, D1
Chu, J1
Huang, H1
Gaiser, S1
Cruz-Monserrate, Z1
Wang, H1
Ji, B1
Logsdon, CD1

Other Studies

1 other study available for camostat and Cell Transformation, Neoplastic

ArticleYear
An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:4

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Ceruletide; Cyclooxygenase 2

2012